...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: BETonMACE baseline data
3
Nov 05, 2018 12:11PM

BETonMACE vs. EXAMINE

Male sex: 74.5% vs. 68%

Mean age: 61 yrs vs. 61 yrs

LDL-C: 65.0 mg/dL (median) vs. 79 mg/dl (mean)

HDL-C: 33.0 mg/dL (median) vs. 43 mg/dL (mean)

HbA1c: 7.3% (median) vs. 8.0% (mean)

Blood pressure: 129/76 mmHg (median) vs. not reported

eGFR<60 ml/min: 11% vs. 29%

Treatment with atorvastatin (40/80mg) or rosuvastatin (20/40mg): 91.6% vs. 90% (on unspecified statin)

Dual anti-platelet therapy: 85% vs. 97% (doesn’t indicate if single or dual therapy)

Index ACS event MI: 75% vs. 77% (EXAMINE also had 23% hospitalization for unstable angina)

Coronary revascularization for index ACS: 78% vs. not listed in EXAMINE table

Median time from index ACS to randomization: 34 days vs. 45 days

 

3
Nov 05, 2018 03:19PM
Share
New Message
Please login to post a reply